Patient Capital Management’s Diamondback Energy FANG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-3,000
Closed -$595K 42
2024
Q1
$595K Sell
3,000
-7,000
-70% -$1.19M 0.03% 42
2023
Q4
$1.55M Hold
10,000
0.08% 39
2023
Q3
$1.55M Hold
10,000
0.09% 37
2023
Q2
$1.31M Hold
10,000
0.07% 40
2023
Q1
$1.35M Sell
10,000
-2,800
-22% -$390K 0.6% 39
2022
Q4
$1.75M Sell
12,800
-16,000
-56% -$2.34M 0.85% 37
2022
Q3
$3.47M Sell
28,800
-4,100
-12% -$512K 1.73% 28
2022
Q2
$3.99M Sell
32,900
-900
-3% -$123K 1.77% 28
2022
Q1
$4.63M Sell
33,800
-40,200
-54% -$5.23M 1.57% 31
2021
Q4
$7.98M Buy
+74,000
New +$8.02M 2.3% 17

Other funds holding FANG

Patient Capital Management's FANG Position: Q2 2024 in Review

Patient Capital Management sold out of Diamondback Energy (FANG) in Q2 2024, closing a stake of 3,000 shares — an estimated $595K sold.

Patient Capital Management first reported a position in FANG in Q4 2021 and held it in 10 quarters. The position peaked at $7.98M in Q4 2021. 1,175 funds tracked by Wall St. Rank hold FANG as of Q2 2024.

  • Patient Capital Management reported no remaining Diamondback Energy position as of Q2 2024 after selling out during the quarter.
  • Patient Capital Management sold 3,000 Diamondback Energy shares in Q2 2024, an estimated $595K.
  • Patient Capital Management first reported a position in Diamondback Energy in Q4 2021 and held it in 10 quarters.
  • Patient Capital Management's Diamondback Energy position peaked at $7.98M in Q4 2021.
  • 1,175 funds tracked by Wall St. Rank held Diamondback Energy as of Q2 2024.

Based on Patient Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.